RISK OF PARKINSON'S DISEASE (PD) IN PATIENTS TAKING ADRENERGIC DRUG TREATMENTS

被引：1
|
作者：
Stacey, J. [1 ]
Lovestone, S. [2 ]
Harrison, P. [2 ]
Denis, M. [2 ]
Nevado-Holgado, A. [2 ]
Newby, D. [2 ]
机构：
[1] TriNetX Inc, Cambridge, MA USA
[2] Univ Oxford, Oxford, England
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
10.1016/j.jval.2018.09.1969
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PND2
引用
收藏
页码：S329 / S329
页数：1
相关论文
共 50 条
  • [21] Quality of life in patients with Parkinson's disease (PD)
    Kim, JW
    Hong, SK
    MOVEMENT DISORDERS, 2002, 17 : S137 - S137
  • [22] Drug therapy in patients with Parkinson’s disease
    Thomas Müller
    Translational Neurodegeneration, 1 (1)
  • [23] Drug therapy in patients with Parkinson's disease
    Mueller, Thomas
    TRANSLATIONAL NEURODEGENERATION, 2012, 1
  • [24] Parkinson's disease treatments in practice: evidence from the PD MED trial
    Clarke, C.
    Patel, S.
    Solanki, V.
    Ives, N.
    Rick, C.
    Gray, R.
    Wheatley, K.
    PARKINSONISM & RELATED DISORDERS, 2009, 15 : S123 - S123
  • [25] Sleep disturbances in drug naive Parkinson's disease (PD) patients and effect of levodopa on sleep
    Ferreira, Teresa
    Prabhakar, Sudesh
    Kharbanda, Parampreet S.
    ANNALS OF INDIAN ACADEMY OF NEUROLOGY, 2014, 17 (04) : 416 - 419
  • [26] Drug treatments and motor complications in advanced stage Parkinson's disease
    Marion, MH
    REVUE NEUROLOGIQUE, 2000, 156 : 160 - 164
  • [27] Evaluating drug treatments for Parkinson's disease: how good are the trials?
    Wheatley, K
    Stowe, RL
    Clarke, CE
    Hills, RK
    Williams, AC
    Gray, R
    BMJ-BRITISH MEDICAL JOURNAL, 2002, 324 (7352): : 1508 - 1511
  • [28] Is hemispheric dominance a risk factor to develop dopamine dysregulation syndrome (DDS), in Parkinson's disease (PD) patients taking dopamine agonists (DA)?
    Moguel-Cobos, G. D.
    Thakur, N.
    Ahmed, A.
    Burns, R. S.
    MOVEMENT DISORDERS, 2008, 23 (01) : S284 - S284
  • [29] Potential Test for Drug Treatments for Parkinson's Disease Using Worms
    不详
    ATLA-ALTERNATIVES TO LABORATORY ANIMALS, 2011, 39 (06): : 502 - 503
  • [30] Dietary risk factors for Parkinson's disease (PD) in twins
    Goldman, SM
    Tanner, CM
    Bhudhikanok, G
    Comyns, K
    Kusumi, M
    Gupta, A
    Meng, C
    Langston, JW
    NEUROLOGY, 2006, 66 (05) : A213 - A213
12345